In-vitro assay for the assessment of post translationally modified protein isoforms

摘要

The present invention relates to an in-vitro bioassay for distinguishing post translationally modified isoforms of a therapeutic protein. In particular the present invention relates to an in-vitro method for distinguishing post translationally modified isoforms of an antibody by C1q based ELISA involving use of a metal ion chelator.